Drug Discovery Today

1

Neurotrophic estrogens: essential profile and endpoints for drug discovery☆

Vladimir K. Patchev, Sergey O. Bachurin, Michael Albers, Karl-Heinrich Fritzemeier, Vassilios Papadopoulos

Journal:

Year:

2008

Language:

english

File:

PDF, 1.59 MB

english, 2008

2

Open-source science to enable drug discovery

Aled Edwards

Journal:

Drug Discovery Today

Year:

2008

Language:

english

File:

PDF, 84 KB

english, 2008

3

In vivo assessment of mitochondrial toxicity

Bradley F. Hamilton, Alan H. Stokes, Jon Lyon, Rick R. Adler

Journal:

Drug Discovery Today

Year:

2008

Language:

english

File:

PDF, 131 KB

english, 2008

4

Targeted imaging: an important biomarker for understanding disease progression in the era of personalized medicine

William C. Eckelman, Richard C. Reba, Gary J. Kelloff

Journal:

Drug Discovery Today

Year:

2008

Language:

english

File:

PDF, 682 KB

english, 2008

5

Male pattern baldness: current treatments, future prospects

Justine A. Ellis, Rodney D. Sinclair

Journal:

Drug Discovery Today

Year:

2008

Language:

english

File:

PDF, 770 KB

english, 2008

6

Cardiotoxicity of the new cancer therapeutics – mechanisms of, and approaches to, the problem

Thomas Force, Risto Kerkelä

Journal:

Drug Discovery Today

Year:

2008

Language:

english

File:

PDF, 358 KB

english, 2008

7

Drug name recognition and classification in biomedical texts: A case study outlining approaches underpinning automated systems

Isabel Segura-Bedmar, Paloma Martínez, María Segura-Bedmar

Journal:

Drug Discovery Today

Year:

2008

Language:

english

File:

PDF, 1.05 MB

english, 2008

8

Emerging treatments for thrombocytopenia: Increasing platelet production

Karen Peeters, Jean-Marie Stassen, Désiré Collen, Chris Van Geet, Kathleen Freson

Journal:

Drug Discovery Today

Year:

2008

Language:

english

File:

PDF, 396 KB

english, 2008

9

Corrigendum to “Targeting mammalian target of rapamycin (mTOR) for health and diseases”

Journal:

Drug Discovery Today

Year:

2008

File:

PDF, 239 KB

2008

10

Addressing informatics challenges in Translational Research with workflow technology

Simon A. Beaulah, Mick A. Correll, Robin E.J. Munro, Jonathan G. Sheldon

Journal:

Drug Discovery Today

Year:

2008

Language:

english

File:

PDF, 2.19 MB

english, 2008

11

The array CGH and its clinical applications

Marwan Shinawi, Sau Wai Cheung

Journal:

Drug Discovery Today

Year:

2008

Language:

english

File:

PDF, 3.46 MB

english, 2008

12

Targeted therapy of cancer using diphtheria toxin-derived immunotoxins

Sirisha Potala, Sanjeeb K. Sahoo, Rama S. Verma

Journal:

Drug Discovery Today

Year:

2008

Language:

english

File:

PDF, 1.26 MB

english, 2008

13

The major gut symbiont reduces its genome when it lives in vitro

Vadim V. Demidov

Journal:

Drug Discovery Today

Year:

2008

Language:

english

File:

PDF, 561 KB

english, 2008

14

Targeted library design for the generation of actives against biological targets: Peptidomimetic inhibitors of myeloid differentiation factor 88

Paul Edwards

Journal:

Drug Discovery Today

Year:

2008

Language:

english

File:

PDF, 142 KB

english, 2008

15

Volume 13; Issue 17-18

Neurotrophic estrogens: essential profile and endpoints for drug discovery☆

Open-source science to enable drug discovery

In vivo assessment of mitochondrial toxicity

Targeted imaging: an important biomarker for understanding disease progression in the era of personalized medicine

Male pattern baldness: current treatments, future prospects

Cardiotoxicity of the new cancer therapeutics – mechanisms of, and approaches to, the problem

Drug name recognition and classification in biomedical texts: A case study outlining approaches underpinning automated systems

Emerging treatments for thrombocytopenia: Increasing platelet production

Corrigendum to “Targeting mammalian target of rapamycin (mTOR) for health and diseases”

Addressing informatics challenges in Translational Research with workflow technology

The array CGH and its clinical applications

Targeted therapy of cancer using diphtheria toxin-derived immunotoxins

The major gut symbiont reduces its genome when it lives in vitro

Targeted library design for the generation of actives against biological targets: Peptidomimetic inhibitors of myeloid differentiation factor 88

Contents

Contents